Countable Labs Funding Round

5/28/2026

Venture Equity

$26,000,000

Undisclosed

The company intends to use the funds to supports its global expansion and enable the development of fit-for-purpose solutions leveraging 10-color capabilities to support cell and gene therapy, minimal residual disease testing (MRD), biomarker validation, vaccine quality control, and other applications.

Private & Independent

Life Sciences

1810 Embarcadero Rd. 200
Palo Alto, CA 94303
USA

Undisclosed

We believe the future of PCR is Countable. Quantification in genomics should finally live up to its promise. We knew that the most essential part of genomics -- quantification -- has been stuck in tools like qPCR, digital PCR, and NGS that require too many tradeoffs to reach true accuracy. From estimation and multiplexing challenges to workflow complexity and overhead, precision has always come at a price. We built Countable PCR to change that. No more compromises. No more estimation. Just true target counts, at single-molecule resolution, with a straightforward workflow -- finally making quantification as direct, reliable, and accessible as it should be.